Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | FLT3 | P36888 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 3/20 | 0.37 |
| ▸ | RAB9A | P51151 | 3/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.37 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.37 |
| ▸ | RELA | Q04206 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CASP3 | P42574 | 1/20 | 0.36 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.36 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.36 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12000722 | 0.98 | MEN1 (0.39) | MEN1KMT2ATDP1HPGDKDM4E | |
| SCHEMBL12000719 | 0.94 | APP (0.35) | MEN1KMT2ATDP1HPGDKDM4E | |
| SCHEMBL16843025 | 0.92 | PTPN5 (0.39) | MEN1KMT2ATDP1HPGDKDM4E | |
| SCHEMBL17118567 | 0.91 | MGLL (0.37) | MEN1KMT2ATDP1HPGDKDM4E | |
| SCHEMBL21365232 | 0.91 | MGLL (0.37) | MEN1KMT2ATDP1HPGDKDM4E | |
| SCHEMBL21365231 | 0.89 | ALDH1A1 (0.37) | MEN1KMT2ATDP1KDM4EALDH1A1 | |
| SCHEMBL12721627 | 0.89 | ALDH1A1 (0.39) | MEN1KMT2ATDP1HPGDKDM4E | |
| SCHEMBL16843031 | 0.89 | ALDH1A1 (0.39) | MEN1KMT2ATDP1HPGDKDM4E | |
| SCHEMBL12721582 | 0.89 | ALDH1A1 (0.39) | MEN1KMT2ATDP1HPGDKDM4E | |
| SCHEMBL17118575 | 0.89 | NPC1 (0.42) | MEN1KMT2ATDP1HPGDKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9343684-B2 | Substituted bisaryloxybiphenyl compounds for use in light-emitting devices | NITTO DENKO CORPORATION (JP) | 2016-05-17 | — | — | US | disclosed |
| US-9343684-B2 | Substituted bisaryloxybiphenyl compounds for use in light-emitting devices | NITTO DENKO CORPORATION (JP) | 2016-05-17 | — | — | US | disclosed |
| US-20140284554-A1 | SUBSTITUTED BISARYLOXYBIPHENYL COMPOUNDS FOR USE IN LIGHT-EMITTING DEVICES | NITTO DENKO CORPORATION (JP) | 2014-09-25 | — | — | US | disclosed |
| US-20140284554-A1 | SUBSTITUTED BISARYLOXYBIPHENYL COMPOUNDS FOR USE IN LIGHT-EMITTING DEVICES | NITTO DENKO CORPORATION (JP) | 2014-09-25 | — | — | US | disclosed |
| US-20120214269-A1 | TETRAPHENYLSILANE COMPOUNDS SUITABLE AS ORGANIC HOLE-TRANSPORT MATERIALS | NITTO DENKO CORPORATION (JP) | 2012-08-23 | — | — | US | disclosed |
| US-20120214269-A1 | TETRAPHENYLSILANE COMPOUNDS SUITABLE AS ORGANIC HOLE-TRANSPORT MATERIALS | NITTO DENKO CORPORATION (JP) | 2012-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120214269-A1 | TETRAPHENYLSILANE COMPOUNDS SUITABLE AS ORGANIC HOLE-TRANSPORT MATERIALS | PAH, SLC7A5, SLCO2A1 | MEN1 225/4885KMT2A 804/4885TDP1 2329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.